alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15282394.
- Also identified by PMC identifier 1747086.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The biochemical and clinical efficacy of intravenous augmentation therapy in alpha(1)-antitrypsin deficiency is reviewed, adverse events experienced with this treatment are considered, and its cost effectiveness is discussed.
Medical subject headings
- alpha 1-Antitrypsin
- alpha 1-Antitrypsin Deficiency